← All trials
NCT04589832
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2020
- Primary completion
- Jun 30, 2021
- Completion date
- Jun 30, 2022
- First posted
- Oct 19, 2020
- Last posted
- Oct 20, 2020
- Enrollment
- 38
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hoosier Cancer Research NetworkLead sponsor
- HealthPartners InstituteCollaborator
- Hoosier Cancer Research NetworkSponsor investigator
- GenentechCollaborator
- Vanquish Oncology, Inc.Collaborator
- HealthPartners InstituteOverall official - principal investigator
- Midwest Melanoma PartnershipCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.